Role of intrapancreatic SPINK1/Spink3 expression in the development of pancreatitis

Frontiers in Physiology

Volumn 3 MAY, Issue , 2012, Pages

  Ohmuraya, Masaki ^a   Sugano, Aki ^b   Hirota, Masahiko ^c   Takaoka, Yutaka ^b   Yamamura, Ken Ichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

Autophagy; Chronic pancreatitis; EGF; EGFR; Hereditary pancreatitis; Spink1; Spink3; Trypsinogen

Indexed keywords

EID: 84866345751     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00126     Document Type: Article

References (74)

1. Archer, H., Jura, N., Keller, J., Jacob-son, M., and Bar-Sagi, D. (2006). A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 131, 1844-1855.
2. Bartelt, D. C., Shapanka, R., and Greene, L. J. (1977). The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein. Arch. Biochem. Biophys. 179, 189-199.
3. Bellu, A. R., and Kiel, J. A. (2003). Selective degradation of peroxisomes in yeasts. Microsc. Res. Tech. 61, 161-170.
4. Braganza, J. M., Lee, S. H., Mccloy, R. F., and Mcmahon, M. J. (2011). Chronic pancreatitis. Lancet 377, 1184-1197.
5. Chen, J. M., Mercier, B., Audrezet, M. P., Raguenes, O., Quere, I., and Ferec, C. (2001). Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 120, 1061-1064.
6. Chera, S., De Rosa, R., Miljkovic-Licina, M., Dobretz, K., Ghila, L., Kaloulis, K., and Galliot, B. (2006). Silencing of the hydra serine protease inhibitor Kazal1 gene mimics the human SPINK1 pancreatic pheno-type. J. Cell. Sci. 119, 846-857.
7. Etemad, B., and Whitcomb, D. C. (2001). Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120, 682-707.
8. Freeman, T. C., Curry, B. J., Calam, J., and Woodburn, J. R. (1990). Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells. Gastroenterology 99, 1414-1420.
9. Fukuoka, S., Fushiki, T., Kitagawa, Y., Sugimoto, E., and Iwai, K. (1987). Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor pep-tide) with epidermal growth factor for binding to 3T3 fibroblasts. Biochem. Biophys. Res. Commun. 145, 646-650.
10. Gaiser, S., Daniluk, J., Liu, Y., Tsou, L., Chu, J., Lee, W., Longnecker, D. S., Logsdon, C. D., and Ji, B. (2011). Intracellular activation of trypsino-gen in transgenic mice induces acute but not chronic pancreatitis. Gut 60, 1379-1388.
11. Gouyer, V., Fontaine, D., Dumont, P., De Wever, O., Fontayne-Devaud, H., Leteurtre, E., Truant, S., Dela-cour, D., Drobecq, H., Kerckaert, J. P., De Launoit, Y., Bracke, M., Gespach, C., Desseyn, J. L., and Huet, G. (2008). Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene 27, 4024-4033.
12. Gullo, L., Barbara, L., and Labo, G. (1988). Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology 95, 1063-1068.
13. Hashimoto, D., Ohmuraya, M., Hirota, M., Yamamoto, A., Suyama, K., Ida, S., Okumura, Y., Takahashi, E., Kido, H., Araki, K., Baba, H., Mizushima, N., and Yamamura, K. (2008). Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells. J. Cell Biol. 181, 1065-1072.
14. Hennig, K. M., and Neufeld, T. P. (2002). Inhibition of cellular growth and proliferation by dTOR overex-pression in Drosophila. Genesis 34, 107-110.
15. Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., Tateishi, R., Matsuura, N., Murata, A., Tomita, N., Monden, T., and Ogawa, M. (1992). Immuno-histochemical analysis of pancreatic secretory trypsin inhibitor expression in pulmonary adenocarcinoma: its possible participation in scar formation of the tumor tissues. Tumour Biol. 13, 299-307.
16. Higashiyama, M., Monden, T., Tomita, N., Murotani, M., Kawasaki, Y., Morimoto, H., Murata,A., Shimano, T., Ogawa, M., and Mori, T. (1990). Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorec-tal cancer. Br. J. Cancer 62, 954-958.
17. Hirota, M., Ohmuraya, M., and Baba, H. (2006). Genetic background of pancreatitis. Postgrad. Med. J. 82, 775-778.
18. Horii, A., Kobayashi, T., Tomita, N., Yamamoto, T., Fukushige, S., Murotsu, T., Ogawa, M., Mori, T., and Matsubara, K. (1987). Primary structure of human pancreatic secretory trypsin inhibitor (PSTI) gene. Biochem. Biophys. Res. Commun. 149, 635-641.
19. Huhtala, M. L., Pesonen, K., Kalkki-nen, N., and Stenman, U. H. (1982). Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J. Biol. Chem. 257, 13713-13716.
20. Hunt, L. T., Barker, W. C., and Dayhoff, M. O. (1974). Epidermal growth factor: internal duplication and probable relationship to pancreatic secretory trypsin inhibitor. Biochem. Bio-phys. Res. Commun. 60, 1020-1028.
21. Ida, S., Ohmuraya, M., Hirota, M., Ozaki, N., Hiramatsu, S., Uehara, H., Takamori, H., Araki, K., Baba, H., and Yamamura, K. (2010). Chronic pancreatitis in mice by treatment with choline-deficient ethionine-supplemented diet. Exp. Anim. 59, 421-429.
22. Jacinto, E., and Hall, M. N. (2003). Tor signalling in bugs, brain and brawn. Nat. Rev. Mol. Cell Biol. 4, 117-126.
23. Kaneko, K., Nagasaki, Y., Furukawa, T., Mizutamari,H.,Sato,A.,Masamune, A., Shimosegawa, T., and Horii, A. (2001). Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis. J. Hum. Genet. 46, 293-297.
24. Kazal, L. A., Spicer, D. S., and Brahinsky, R. A. (1948). Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. J. Am. Chem. Soc. 70, 304-340.
25. Kim, J., and Klionsky, D. J. (2000). Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. Annu. Rev. Biochem. 69, 303-342.
26. Kiraly, O., Wartmann, T., and Sahin-Toth, M. (2007). Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellu-lar retention and degradation. Gut 56, 1433-1438.
27. Klionsky, D. J. (2005). The molecular machinery of autophagy: unanswered questions. J. Cell. Sci. 118, 7-18.
28. Kuwata, K., Hirota, M., Nishimori, I., Otsuki, M., and Ogawa, M. (2003). Mutational analysis of the pancreatic secretory trypsin inhibitor gene in familial and juvenile pancreatitis in Japan. J. Gastroenterol. 38, 365-370.
29. Kuwata, K., Hirota, M., Shimizu, H., Nakae, M., Nishihara, S., Taki-moto, A., Mitsushima, K., Kikuchi, N., Endo, K., Inoue, M., and Ogawa, M. (2002). Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J. Gas-troenterol. 37, 928-934.
30. Kuwata, K., Hirota, M., Sugita, H., Kai, M., Hayashi, N., Nakamura, M., Matsuura, T., Adachi, N., Nishi-mori, I., and Ogawa, M. (2001). Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J. Gastroenterol. 36, 612-618.
31. Lemasters, J. J., Qian, T., He, L., Kim, J. S., Elmore, S. P., Cascio, W. E., and Brenner, D. A. (2002). Role of mitochondrialinner membrane per-meabilization in necrotic cell death, apoptosis, and autophagy. Antioxid. Redox Signal. 4, 769-781.
32. Lowenfels, A. B., and Maisonneuve, P. (2005). Risk factors for pancreatic cancer. J. Cell. Biochem. 95, 649-656.
33. Lowenfels, A. B., Maisonneuve, P., Dimagno, E. P., Elitsur, Y., Gates, L. K. Jr., Perrault, J., and Whitcomb, D. C. (1997). Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl. Cancer Inst. 89, 442-446.
34. Marchbank, T., Chinery, R., Hanby, A. M., Poulsom, R., Elia, G., and Playford, R. J. (1996). Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution. Am. J. Pathol. 148, 715-722.
35. Marchbank, T., Freeman, T. C., and Playford, R. J. (1998). Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair. Digestion 59, 167-174.
36. McKeehan, W. L., Sakagami, Y., Hoshi, H., and Mckeehan, K. A. (1986). Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J. Biol. Chem. 261, 5378-5383.
37. Meijer, A. J. (2003). Amino acids as regulators and components of non-proteinogenic pathways. J. Nutr.133, 2057S-2062S.
38. Melendez, A., Talloczy, Z., Seaman, M., Eskelinen, E. L., Hall, D. H., and Levine, B. (2003). Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 301, 1387-1391.
39. Mergener, K., and Baillie, J. (1997). Chronic pancreatitis. Lancet 350, 1379-1385.
40. Mizushima, N. (2005). The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ. 12(Suppl. 2), 1535-1541.
41. Mizushima, N., Levine, B., Cuervo, A. M., and Klionsky, D. J. (2008). Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075.
42. Neuschwander-Tetri, B. A., Burton, F. R., Presti, M. E., Britton, R. S., Janney, C. G., Garvin, P. R., Brunt, E. M., Galvin,N. J., and Poulos,J. E. (2000). Repetitive self-limited acute pancreatitis induces pancreatic fibrogene-sis in the mouse. Dig. Dis. Sci. 45, 665-674.
43. Niinobu, T., Ogawa, M., Murata, A., Nishijima, J., and Mori, T. (1990). Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor. J. Exp. Med. 172, 1133-1142.
44. Nishimori, I., Kamakura, M., Fujikawa-Adachi, K., Morita, M., Onishi, S., Yokoyama, K., Makino, I., Ishida, H., Yamamoto, M., Watanabe, S., and Ogawa, M. (1999). Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 44, 259-263.
45. Ogawa, M., Matsuura, N., Higashiyama, K., and Mori, T. (1987). Expression of pancreatic secretory trypsin inhibitor in various cancer cells. Res. Commun. Chem. Pathol. Pharmacol. 55, 137-140.
46. Ogawa, M., Tsushima, T., Ohba, Y., Ogawa, N., Tanaka, S., Ishida, M., and Mori, T. (1985). Stimulation of DNA synthesis in human fibrob-lasts by human pancreatic secretory trypsin inhibitor. Res. Commun. Chem. Pathol. Pharmacol. 50, 155-158.
47. Ohmachi, Y., Murata, A., Matsuura, N., Yasuda, T., Monden, M., Mori, T., Ogawa, M., and Matsubara, K. (1993). Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. Int. J. Cancer 55, 728-734.
48. Ohmuraya, M., Hirota, M., Araki, K., Baba, H., and Yamamura, K. (2006). Enhanced trypsin activity in pancreatic acinar cells deficient for serine protease inhibitor Kazal type 3. Pancreas 33, 104-106.
49. Ohmuraya, M., Hirota, M., Araki, M., Mizushima, N., Matsui, M., Mizumoto, T., Haruna, K., Kume, S., Takeya, M., Ogawa, M., Araki, K., and Yamamura, K. (2005). Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology 129, 696-705.
50. Ohmuraya, M., Ozaki, N., Hirota, M., Baba, H., and Yamamura, K. (2009). Serine protease inhibitor Kazal type 1 (SPINK1): beyond the trypsin inhibitor. Curr. Enzym. Inhib. 5, 110-116.
51. Ohmuraya, M., and Yamamura, K. (2008). Autophagy and acute pancreatitis: a novel autophagy theory for trypsinogen activation. Autophagy 4, 1060-1062.
52. Otto, G. P., Wu, M. Y., Kazgan, N., Anderson, O. R., and Kessin, R. H. (2003). Macroautophagy is required for multicellular development of the social amoeba Dic-tyostelium discoideum. J. Biol. Chem. 278, 17636-17645.
53. Ozaki, N., Ohmuraya, M., Hirota, M., Ida, S., Wang, J., Takamori, H., Higashiyama, S., Baba, H., and Yamamura, K. (2009). Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Mol. Cancer Res. 7, 1572-1581.
54. Paju, A., and Stenman, U. H. (2006). Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor. Crit. Rev. Clin. Lab. Sci. 43, 103-142.
55. Pfutzer, R. H., Barmada, M. M., Brunskill, A. P., Finch, R., Hart, P. S., Neoptolemos, J., Furey, W. F., and Whitcomb, D. C. (2000). SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119, 615-623.
56. Roberts, P., Moshitch-Moshkovitz, S., Kvam, E., O'toole, E., Winey,M., and Goldfarb, D. S. (2003). Piecemeal microautophagy of nucleus in Sac-charomyces cerevisiae. Mol. Biol. Cell 14, 129-141.
57. Sahin-Toth, M., and Toth, M. (2000). Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem. Biophys. Res. Commun. 278, 286-289.
58. Scheving, L. A. (1983). Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family. Arch. Biochem. Biophys. 226, 411-413.
59. Seglen, P. O., and Bohley, P. (1992). Autophagy and other vacuolar protein degradation mechanisms. Experientia 48, 158-172.
60. Steer, M. L., Waxman, I., and Freedman, S. (1995). Chronic pancreatitis. N. Engl. J. Med. 332, 1482-1490.
61. Stenman, U. H., Huhtala, M. L., Koisti-nen, R., and Seppala, M. (1982). Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int. J. Cancer 30, 53-57.
62. Stenman, U. H., Koivunen, E., and Itko-nen, O. (1991). Biology and function of tumor-associated trypsin inhibitor, TATI. Scand. J. Clin. Lab. Invest. Suppl. 207, 5-9.
63. Teich, N., Rosendahl, J., Toth, M., Mossner, J., and Sahin-Toth, M. (2006). Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum. Mutat. 27, 721-730.
64. Tomita, N., Doi, S., Higashiyama, M., Morimoto, H., Murotani, M., Kawasaki, Y., Monden, T., Shimano, T., Horii, A., Yokouchi, H., Ogawa, M., Mori, T., and Matsubara, K. (1990). Expression of pancreatic secretory trypsin inhibitor gene in human colorectal tumor. Cancer 66, 2144-2149.
65. Tomita, N., Horii, A., Yamamoto, T., Ogawa, M., Mori, T., and Matsubara, K. (1987). Expression of pancreatic secretory trypsin inhibitor gene in neoplastic tissues. FEBS Lett. 225, 113-119.
66. Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X. W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J. E., Shah, R. B., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. (2005). Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648.
67. Tomlins, S. A., Rhodes, D. R., Yu, J., Varambally, S., Mehra, R., Perner, S., Demichelis, F., Helgeson, B. E., Lax-man, B., Morris, D. S., Cao, Q., Cao, X., Andren, O., Fall, K., Johnson, L., Wei, J. T., Shah, R. B., Al-Ahmadie, H., Eastham, J. A., Eggener, S. E., Fine, S. W., Hotakainen, K., Sten-man, U. H., Tsodikov, A., Gerald, W. L., Lilja, H., Reuter, V. E., Kantoff, P. W., Scardino, P. T., Rubin, M. A., Bjartell, A. S., and Chinnaiyan, A. M. (2008). The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell 13, 519-528.
68. Tonouchi, A., Ohtsuka, M., Ito, H., Kimura, F., Shimizu, H., Kato, M., Nimura, Y., Iwase, K., Hiwasa, T., Seki, N., Takiguchi, M., and Miyazaki, M. (2006). Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocar-cinoma following surgical resection. Am. J. Gastroenterol. 101, 1601-1610.
69. Whitcomb, D. C. (2004). Inflammation and cancer V. Chronic pancreatitis and pancreatic cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G315-G319.
70. Whitcomb, D. C. (2010). Genetic aspects of pancreatitis. Annu. Rev. Med. 61, 413-424.
71. Whitcomb, D. C., Gorry, M. C., Preston, R. A., Furey, W., Sossenheimer, M. J., Ulrich, C. D., Martin, S. P., Gates, L. K. Jr., Amann, S. T., Toskes, P. P., Liddle, R., Mcgrath, K., Uomo, G., Post, J. C., and Ehrlich, G. D. (1996). Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 14, 141-145.
72. Witt, H., Luck, W., Hennies, H. C., Classen, M., Kage, A., Lass, U., Landt, O., and Becker, M. (2000). Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat. Genet. 25, 213-216.
73. Witt, H., Sahin-Toth, M., Landt, O., Chen, J. M., Kahne, T., Drenth, J. P., Kukor, Z., Szepessy, E., Halangk, W., Dahm, S., Rohde, K., Schulz, H. U., Le Marechal, C., Akar, N., Ammann, R. W., Truninger, K., Bar-getzi, M., Bhatia, E., Castellani, C., Cavestro, G. M., Cerny, M., Destro-Bisol, G., Spedini, G., Eiberg, H., Jansen, J. B., Koudova, M., Rausova, E., Macek, M. Jr., Malats, N., Real, F. X., Menzel, H. J., Moral, P., Galavotti, R., Pignatti, P. F., Rickards, O., Spicak, J., Zarnescu, N. O., Bock, W., Gress, T. M., Friess, H., Ockenga, J., Schmidt, H., Pfutzer, R., Lohr, M., Simon, P., Weiss, F. U., Lerch, M. M., Teich, N., Keim, V., Berg, T., Wieden-mann, B., Luck, W., Groneberg, D. A., Becker, M., Keil, T., Kage, A., Bernardova, J., Braun, M., Guldner, C., Halangk, J., Rosendahl, J., Witt, U., Treiber, M., Nickel, R., and Ferec, C. (2006). A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat. Genet. 38, 668-673.
74. Yamamoto, T., Nakamura, Y., Nishide, J., Emi, M., Ogawa, M., Mori, T., and Matsubara, K. (1985). Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNA. Biochem. Biophys. Res. Commun. 132, 605-612.